- Record: Senate Floor
- Section type: Executive business
- Chamber: Senate
- Date: April 20, 2026
- Congress: 119th Congress
- Why this source matters: This section came from the Senate floor portion of the record.
- RIN: 0938-AV63
with accompanying papers, reports, and documents, and were referred as indicated:
EC-3173. A communication from the Chief Operating Officer,
Board of Governors of the Federal Reserve System,
transmitting, pursuant to law, the Board's fiscal year 2025
annual report relative to the Notification and Federal
Employee Antidiscrimination and Retaliation Act of 2002 (No
FEAR Act) received in the Office of the President pro
tempore; to the Committee on Homeland Security and
Governmental Affairs.
EC-3174. A communication from the Director, Federal
Election Commission, transmitting, pursuant to law, the
Commission's fiscal year 2025 annual report relative to the
Notification and Federal Employee Antidiscrimination and
Retaliation Act of 2002 (No FEAR Act) received in the Office
of the President pro tempore; to the Committee on Homeland
Security and Governmental Affairs.
EC-3175. A communication from the Director, Office of
Equal Employment Opportunity, National Archives and Records
Administration, transmitting, pursuant to law, the
Administration's fiscal year 2025 annual report relative to
the Notification and Federal Employee Antidiscrimination and
Retaliation Act of 2002 (No FEAR Act) received in the Office
of the President pro tempore; to the Committee on Homeland
Security and Governmental Affairs.
EC-3176. A communication from the Regulations Coordinator,
Centers for Medicare and Medicaid Services, Department of
Health and Human Services, transmitting, pursuant to law, the
report of a rule entitled “Medicare Program; Contract Year
2027 and Certain Contract Year 2026 Policy and Technical
Changes to the Medicare Advantage Program, Medicare
Prescription Drug Benefit Program, and Medicare Cost Plan
Program” (RIN0938-AV63) (CMS-4212-F) received during
adjournment of the Senate in the Office of the President of
the Senate on April 8, 2026; to the Committee on Finance.
EC-3177. A communication from the Regulations Coordinator,
Centers for Medicare and Medicaid Services, Department of
Health and Human Services, transmitting, pursuant to law, the
report of a rule entitled “Announcement of Calendar Year
(CY) 2027 Medicare Advantage (MA) Capitation Rates and Part C
and Part D Payment Policies” (RIN0938-ZC02) received during
adjournment of the Senate in the Office of the President of
the Senate on April 8, 2026; to the Committee on Finance.
EC-3178. A communication from the Social Insurance
Specialist, Social Security Administration, transmitting,
pursuant to law, the report of a rule entitled “Rescission
of Obsolete Regulations Addressing Drug Addiction and
Alcoholism Under Titles II and XVI of the Social Security
Act” (RIN0960-AJ05) received during the adjournment of the
Senate in the Office of the President of the Senate on April
13, 2026; to the Committee on Finance.
EC-3179. A communication from the Board Chairman and Chief
Executive Officer, Farm Credit Administration, transmitting,
pursuant to law, the Administration's Fiscal Year 2025
Federal Information Security Management Act (FISMA) and
Privacy Management Requirements; to the Committee on
Agriculture, Nutrition, and Forestry.
EC-3180. A communication from the Senior Bureau Official,
Legislative Affairs, Department of State, transmitting,
pursuant to law, a report relative to the authorization of
danger pay in Belize and the Dominican Republic; to the
Committee on Foreign Relations.
EC-3181. A communication from the Assistant Secretary for
Legislation, Department of Health and Human Services,
transmitting, pursuant to law, a report entitled “Scarlett's
Sunshine on Sudden Unexpected Death Act”; to the Committee
on Health, Education, Labor, and Pensions.
EC-3182. A communication from the Deputy Assistant
Administrator of the Diversion Control Division, Drug
Enforcement Administration, Department of Justice,
transmitting, pursuant to law, the report of a rule entitled
“Fourth Temporary Extension of COVID-19 Telemedicine
Flexibilities for Prescription of Controlled Medications”
((RIN1117-AB40) (RIN1117-AB78) (RIN1117-ZA07) (Docket No.
DEA-407)) received during adjournment of the Senate in the
Office of the President of the Senate on April 13, 2026; to
the Committee on Health, Education, Labor, and Pensions.
EC-3183. A communication from the Deputy Assistant
Administrator of the Diversion Control Division, Drug
Enforcement Administration, Department of Justice,
transmitting, pursuant to law, the report of a rule entitled
“Schedules of Controlled Substances: Extension of Temporary
Placement of CUMYL-PEGACLONE in Schedule 1 of Controlled
Substances Act” ((21 CFR Part 1308) (Docket No. DEA-1511))
received during adjournment of the Senate in the Office of
the President of the Senate on April 13, 2026; to the
Committee on the Judiciary.
EC-3184. A communication from the Deputy Assistant
Administrator of the Diversion Control Division, Drug
Enforcement Administration, Department of Justice,
transmitting, pursuant to law, the report of a rule entitled
“Definition of `Cannabimimetic Agents' and Assignment of an
Administration Controlled Substances Code number for all
`Cannabimimetic Agents' ” (Docket No. DEA-368) received
during adjournment of the Senate in the Office of the
President of the Senate on April 13, 2026; to the Committee
on the Judiciary.
EC-3185. A communication from the Deputy Assistant
Administrator of the Diversion Control Division, Drug
Enforcement Administration, Department of Justice,
transmitting, pursuant to law, the report of a rule entitled
“Schedules of Controlled Substances: Extension of Temporary
Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA,
and MMB-FUBICA in Schedule I of the Controlled Substances
Act” ((21 CFR Part 1308) (Docket No. DEA-1604)) received
during adjournment of the Senate in the Office of the
President of the Senate on April 13, 2026; to the Committee
on the Judiciary.